Modeling and targeting of erythroleukemia by hematopoietic genome editingIlaria Iacobucci, Charles G. Mullighan, Burgess B. Freeman et al.|Blood|2021Cited by 43
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALLIlaria Iacobucci, Charles G. Mullighan, Reiji Fukano et al.|Blood Advances|2022Cited by 3
Patient-derived pediatric brain tumor orthotopic xenografts and tumor organoids faithfully recapitulate primary tumorsJustin S. Williams, Martine F. Roussel, Dana M. Farmer et al.|Science Advances|2026Cited by 1
AML-144 Uroporphyrinogen Decarboxylase (UROD) Is a Therapeutically Targetable Dependency in Acute Erythroid LeukemiaJake D. Friske, Ilaira Lacobucci, Yu Fukuda et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
Poster: AML-144 Uroporphyrinogen Decarboxylase (UROD) Is a Therapeutically Targetable Dependency in Acute Erythroid LeukemiaJake D. Friske, Ilaira Iacobucci, Yu Fukuda et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0